Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Laponis Adam, holds the title of Chief Financial Officer at Twist Bioscience Corp.
On 2026-11-16, the insider transacted 14,187 shares.The price in this filing could not be confirmed (price far from other filings for this stock), so no dollar value is shown. The SEC filing has the figures as filed.
Laponis Adam (Chief Financial Officer) sold shares of $TWST (value not verified)
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.